These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32812130)

  • 1. The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.
    Uzlu D; Erdöl H; Kola M; Özbay AD
    Lasers Med Sci; 2021 Jul; 36(5):981-988. PubMed ID: 32812130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.
    Kim JY; Park HS; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2129-35. PubMed ID: 25717024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Grzybowski A
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2299-2306. PubMed ID: 28831603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy.
    Maruko I; Koizumi H; Hasegawa T; Arakawa H; Iida T
    PLoS One; 2017; 12(8):e0184112. PubMed ID: 28850595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy.
    Malik KJ; Sampat KM; Mansouri A; Steiner JN; Glaser BM
    Retina; 2015 Mar; 35(3):532-6. PubMed ID: 25127050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years.
    Kim YJ; Kim SY; Ha S; Moon D; Seong S; Kwon OW; Park HS
    Eye (Lond); 2019 May; 33(5):819-825. PubMed ID: 30610228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
    Yadav NK; Jayadev C; Mohan A; Vijayan P; Battu R; Dabir S; Shetty B; Shetty R;
    Eye (Lond); 2015 Feb; 29(2):258-64; quiz 265. PubMed ID: 25613846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy.
    Altınel MG; Acikalin B; Gunes H; Demir G
    Lasers Med Sci; 2021 Sep; 36(7):1505-1514. PubMed ID: 33409750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot prospective study of 577-nm yellow subthreshold micropulse laser treatment with two different power settings for acute central serous chorioretinopathy.
    Zhou L; Chong V; Lai K; Huang C; Xu F; Gong Y; Youlidaxi M; Li T; Lu L; Jin C
    Lasers Med Sci; 2019 Sep; 34(7):1345-1351. PubMed ID: 30710172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of changes in macular structures after subthreshold micropulse laser therapy on chronic central serous chorioretinopathy.
    Liu L; Xu Q; Song X; Zhao Y; Zhang Y; Qu Y
    Lasers Med Sci; 2024 Feb; 39(1):83. PubMed ID: 38418639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological and anatomical outcomes of subthreshold micropulse laser therapy in chronic central serous chorioretinopathy.
    Kayhan B; Demir N; Sevincli S; Sonmez M
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103221. PubMed ID: 36464217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOW-INTENSITY/HIGH-DENSITY SUBTHRESHOLD DIODE MICROPULSE LASER FOR CENTRAL SEROUS CHORIORETINOPATHY.
    Luttrull JK
    Retina; 2016 Sep; 36(9):1658-63. PubMed ID: 27206160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy.
    Beniwal A; Shaikh N; Chawla R; Azad SV; Kumar V; Vohra R
    Indian J Ophthalmol; 2022 Sep; 70(9):3341-3345. PubMed ID: 36018117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy.
    Zeng M; Chen X; Song Y; Cai C
    BMC Ophthalmol; 2022 Mar; 22(1):110. PubMed ID: 35260118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study.
    Long H; Liu M; Hu Q; Li X
    BMC Ophthalmol; 2022 Mar; 22(1):105. PubMed ID: 35248003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Feenstra HMA; Hahn LC; van Rijssen TJ; Tsonaka R; Breukink MB; Keunen JEE; Peters PJH; Dijkman G; Souied EH; MacLaren RE; Querques G; Downes SM; Fauser S; Hoyng CB; van Dijk EHC; Boon CJF
    Retina; 2022 Apr; 42(4):721-729. PubMed ID: 34864802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
    Roca JA; Wu L; Fromow-Guerra J; Rodríguez FJ; Berrocal MH; Rojas S; Lima LH; Gallego-Pinazo R; Chhablani J; Arevalo JF; Lozano-Rechy D; Serrano M
    Br J Ophthalmol; 2018 Dec; 102(12):1696-1700. PubMed ID: 29439089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.